CNSP: Cns Pharmaceuticals Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Cns Pharmaceuticals Inc (CNSP).
$6.92M Market Cap.
CNSP Market Cap. (MRY)
CNSP Shares Outstanding (MRY)
CNSP Assets (MRY)
Total Assets
$8.70M
Total Liabilities
$2.52M
Total Investments
$0
CNSP Income (MRY)
Revenue
$0
Net Income
-$14.86M
Operating Expense
$14.90M
CNSP Cash Flow (MRY)
CF Operations
-$17.11M
CF Investing
-$4.19K
CF Financing
$23.03M
CNSP Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $8,700,943 (411.56%) | $1,700,853 (-86.97%) | $13,053,115 (49.05%) | $8,757,385 (-44.76%) |
Assets Current | $8,658,508 (444.16%) | $1,591,170 (-87.34%) | $12,564,645 (68.03%) | $7,477,450 (-51.75%) |
Assets Non-Current | $42,435 (-61.31%) | $109,683 (-77.55%) | $488,470 (-61.84%) | $1,279,935 (257.95%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $6,176,611 (239.36%) | -$4,432,115 (-154.50%) | $8,132,856 (31.96%) | $6,163,197 (-55.81%) |
Property Plant & Equipment Net | $6,005 (21.73%) | $4,933 (-12.91%) | $5,664 (-64.84%) | $16,109 (-31.25%) |
Cash & Equivalents | $6,461,378 (1077.53%) | $548,721 (-94.54%) | $10,055,407 (100.93%) | $5,004,517 (-64.35%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,198,260 (-62.31%) | $5,832,162 (29.31%) | $4,510,291 (127.63%) | $1,981,445 (109.38%) |
Accumulated Retained Earnings (Deficit) | -$84,424,704 (-21.36%) | -$69,566,903 (-37.17%) | -$50,715,677 (-43.10%) | -$35,441,543 (-69.20%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $326,072 (8.40%) | $300,806 (-26.63%) | $409,968 (5.72%) | $387,794 (-11.72%) |
Debt Current | $326,072 (8.40%) | $300,806 (-26.63%) | $409,968 (5.72%) | $387,794 (-11.72%) |
Debt Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Liabilities | $2,524,332 (-58.84%) | $6,132,968 (24.65%) | $4,920,259 (89.66%) | $2,594,188 (36.15%) |
Liabilities Current | $2,524,332 (-58.84%) | $6,132,968 (24.65%) | $4,920,259 (89.66%) | $2,594,188 (36.15%) |
Liabilities Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
CNSP Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $5,611,800 (17.66%) | $4,769,502 (-20.07%) | $5,967,052 (27.48%) | $4,680,840 (6.56%) |
Research & Development Expense | $9,290,143 (-34.09%) | $14,095,606 (51.56%) | $9,300,055 (-5.15%) | $9,805,075 (93.71%) |
Operating Expenses | $14,901,943 (-21.01%) | $18,865,108 (23.57%) | $15,267,107 (5.39%) | $14,485,915 (53.22%) |
Interest Expense | $16,120 (16.77%) | $13,805 (96.46%) | $7,027 (-24.32%) | $9,285 (184.47%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$14,857,801 (21.18%) | -$18,851,226 (-23.42%) | -$15,274,134 (-5.37%) | -$14,495,200 (-53.26%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$14,857,801 (21.18%) | -$18,851,226 (-23.42%) | -$15,274,134 (-5.37%) | -$14,495,200 (-53.26%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$14,857,801 (21.18%) | -$18,851,226 (-23.42%) | -$15,274,134 (-5.37%) | -$14,495,200 (-53.26%) |
Weighted Average Shares | $382,241 (-89.85%) | $3,767,372 (176.66%) | $1,361,737 (55.02%) | $878,443 (58.58%) |
Weighted Average Shares Diluted | $382,241 (-89.85%) | $3,767,372 (176.66%) | $1,361,737 (55.02%) | $878,443 (58.58%) |
Earning Before Interest & Taxes (EBIT) | -$14,841,681 (21.21%) | -$18,837,421 (-23.39%) | -$15,267,107 (-5.39%) | -$14,485,915 (-53.22%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$14,901,943 (21.01%) | -$18,865,108 (-23.57%) | -$15,267,107 (-5.39%) | -$14,485,915 (-53.22%) |
CNSP Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$4,188 (-7.36%) | -$3,901 (11.78%) | -$4,422 (23.07%) | -$5,748 (67.97%) |
Net Cash Flow from Financing | $23,030,144 (396.63%) | $4,637,246 (-70.30%) | $15,613,127 (246.26%) | $4,509,081 (-68.10%) |
Net Cash Flow from Operations | -$17,113,299 (-21.03%) | -$14,140,031 (-33.93%) | -$10,557,815 (22.02%) | -$13,538,309 (-85.00%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $5,912,657 (162.19%) | -$9,506,686 (-288.22%) | $5,050,890 (155.90%) | -$9,034,976 (-232.90%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$4,188 (-7.36%) | -$3,901 (11.78%) | -$4,422 (23.07%) | -$5,748 (67.97%) |
Issuance (Repayment) of Debt Securities | -$300,806 (31.44%) | -$438,733 (-2.58%) | -$427,700 (10.43%) | -$477,490 (-1008.35%) |
Issuance (Purchase) of Equity Shares | $23,397,700 (343.24%) | $5,278,838 (-67.09%) | $16,040,827 (221.68%) | $4,986,571 (-64.94%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $838,957 (-16.72%) | $1,007,417 (-16.26%) | $1,202,966 (-30.22%) | $1,723,842 (33.28%) |
Depreciation Amortization & Accretion | $3,306 (-20.03%) | $4,134 (-64.83%) | $11,756 (-10.05%) | $13,070 (17.79%) |
CNSP Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -7384.30% (-122.19%) | 33276.20% (23435.34%) | -142.60% (4.30%) | -149.00% (-2.48%) |
Return on Average Assets (ROAA) | -293.60% (30.33%) | -421.40% (-251.75%) | -119.80% (1.56%) | -121.70% (6.60%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 416.80% (-43.15%) | 733.20% (163.01%) | -1163.60% (-71.52%) | -678.40% (44.22%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.15 (38.98%) | -0.25 (-18.69%) | -0.21 (83.24%) | -1.28 (59.11%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.12 (174.53%) | -1.5 (-481.73%) | 0.39 (-87.62%) | 3.18 (49.74%) |
Debt to Equity Ratio (D/E) | 0.41 (129.55%) | -1.38 (-328.76%) | 0.6 (43.71%) | 0.42 (207.30%) |
Earnings Per Share (EPS) | -38.87 (-677.40%) | -5 (55.44%) | -11.22 (32.00%) | -16.5 (3.51%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -44.78 (-1092.91%) | -3.75 (51.60%) | -7.76 (49.70%) | -15.42 (-16.42%) |
Book Value Per Share (BVPS) | 16.16 (1474.06%) | -1.18 (-119.69%) | 5.97 (-14.88%) | 7.02 (-72.14%) |
Tangible Assets Book Value Per Share (TABVPS) | 22.76 (4947.23%) | 0.45 (-95.30%) | 9.59 (-3.84%) | 9.97 (-65.17%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 0 (0%) | -1 (66.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 0 (100.32%) | -0.31 (-224.19%) | 0.25 (131.67%) | -0.78 (73.90%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 3.43 (1224.32%) | 0.26 (-89.86%) | 2.55 (-11.38%) | 2.88 (-64.56%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$17,117,487 (-21.02%) | -$14,143,932 (-33.91%) | -$10,562,237 (22.02%) | -$13,544,057 (-84.63%) |
Enterprise Value (EV) | -$20,538 (-100.35%) | $5,798,076 (253.16%) | -$3,785,644 (-133.41%) | $11,330,096 (-60.01%) |
Earnings Before Tax (EBT) | -$14,857,801 (21.18%) | -$18,851,226 (-23.42%) | -$15,274,134 (-5.37%) | -$14,495,200 (-53.26%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$14,838,375 (21.21%) | -$18,833,287 (-23.45%) | -$15,255,351 (-5.41%) | -$14,472,845 (-53.26%) |
Invested Capital | $41,305 (100.88%) | -$4,680,030 (-209.41%) | -$1,512,583 (-197.81%) | $1,546,474 (344.66%) |
Working Capital | $6,134,176 (235.06%) | -$4,541,798 (-159.41%) | $7,644,386 (56.54%) | $4,883,262 (-64.07%) |
Tangible Asset Value | $8,700,943 (411.56%) | $1,700,853 (-86.97%) | $13,053,115 (49.05%) | $8,757,385 (-44.76%) |
Market Capitalization | $6,921,399 (3.84%) | $6,665,719 (108.14%) | $3,202,566 (-83.67%) | $19,611,687 (-33.84%) |
Average Equity | $201,207 (455.17%) | -$56,651 (-100.53%) | $10,713,126 (10.12%) | $9,728,470 (49.54%) |
Average Assets | $5,060,090 (13.10%) | $4,473,810 (-64.92%) | $12,752,555 (7.06%) | $11,912,002 (64.10%) |
Invested Capital Average | -$3,560,712 (-38.60%) | -$2,569,118 (-295.80%) | $1,312,111 (-38.55%) | $2,135,378 (174.70%) |
Shares | 1,149,734 (-78.09%) | 5,248,598 (293.33%) | 1,334,403 (43.38%) | 930,690 (67.67%) |
